MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsubery, H.
Right arrow Articles by Fridkin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsubery, H.
Right arrow Articles by Fridkin, M.

Vol. 62, Issue 5, 1036-1042, November 2002

Modulation of the Hydrophobic Domain of Polymyxin B Nonapeptide: Effect on Outer-Membrane Permeabilization and Lipopolysaccharide Neutralization

Haim Tsubery, Itzhak Ofek, Sofia Cohen, Miriam Eisenstein, and Mati Fridkin

Department of Organic Chemistry (H.T., M.F.) and Chemical Services Unit (M.E.), the Weizmann Institute of Science, Rehovot, Israel; and Department of Human Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv Israel (H.T., I.O., S.C.)

Polymyxin B nonapeptide (PMBN), a cationic cyclic peptide derived from the antibacterial peptide polymyxin B, is capable of specifically increasing the permeability of the outer membrane (OM) of Gram-negative bacteria toward hydrophobic antibiotics. In this study, we evaluated the contribution of the hydrophobic segment of PMBN (i.e., D-Phe5-Leu6) to this activity. Accordingly, we synthesized four analogs of PMBN by replacing D-Phe5 with either with D-Trp or D-Tyr and Leu6 with Phe or Ala and evaluated their ability to bind cell-free lipopolysaccharide (LPS) and increase bacterial OM permeability. Compared with PMBN, [D-Tyr5]PMBN and [Ala6]PMBN possessed reduced LPS affinity (IC50 = 2.5, 25, and 12 µM, respectively) and significantly reduced OM permeability and LPS neutralization activity. [Phe6]PMBN exhibited rather similar affinity to cell-free LPS (IC50 = 5 µM) and the same OM permeability capacity as PMBN. However, [D-Trp5]PMBN, despite its similar affinity to cell-free LPS (IC50 = 4 µM), had moderately reduced OM permeability capacity. These results demonstrate the significant role of the PMBN hydrophobic segment in promoting biological activity.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J Med MicrobiolHome page
S. Fadel and A. Eley
Is lipopolysaccharide a factor in infectivity of Chlamydia trachomatis?
J. Med. Microbiol., March 1, 2008; 57(3): 261 - 266.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Tsubery, H. Yaakov, S. Cohen, T. Giterman, A. Matityahou, M. Fridkin, and I. Ofek
Neopeptide Antibiotics That Function as Opsonins and Membrane-Permeabilizing Agents for Gram-Negative Bacteria
Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3122 - 3128.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
K. Gregory and C. M. Mello
Immobilization of Escherichia coli Cells by Use of the Antimicrobial Peptide Cecropin P1
Appl. Envir. Microbiol., March 1, 2005; 71(3): 1130 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. R. Lewis and S. A. Lewis
Colistin interactions with the mammalian urothelium
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C913 - C922.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
H. Nikaido
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Microbiol. Mol. Biol. Rev., December 1, 2003; 67(4): 593 - 656.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics